Biocon Biologics receives Health Canada approval for Yesafili
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
The transaction is expected to close in Q2 FY 2026
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Subscribe To Our Newsletter & Stay Updated